Approach to Patients with Allergic Rhinitis Testing and Treatment

被引：16

作者：

Cox, Linda ^{[1
,2
,3
]}

机构：

[1] Nova Southeastern Univ, Dept Med, Davie, FL USA

[2] Univ Miami, Dept Med, Coral Gables, FL 33124 USA

[3] 1108 South Wolcott St, Casper, WY 82601 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2020年 / 104卷 / 01期

关键词：

Allergen immunotherapy; Sublingual immunotherapy; Pharmacoeconomics; Allergic rhinitis; Subcutaneous immunotherapy; Standard drug treatment; Antihistamines; Nasal corticosteroids; POLLEN INDUCED RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY; SUBCUTANEOUS IMMUNOTHERAPY; COST-EFFECTIVENESS; ORAL IMMUNOTHERAPY; ECONOMIC-EVALUATION; UNITED-STATES; ENVIRONMENTAL ASSESSMENT; SYMPTOMATIC TREATMENT; SYSTEMIC REACTIONS;

D O I：

10.1016/j.mcna.2019.09.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article evaluates the role of allergen immunotherapy (AIT) in the treatment of allergic rhinitis (AR). AIT has been shown to be effective in treating AR symptoms with resultant improvements in overall quality of life, comorbid illnesses, and medication requirements. Persistent clinical benefits have been shown years after AIT treatment discontinuation. AIT may prevent the progression of AR to asthma. AIT may more cost-effective than pharmacotherapy. Multiple individual studies and systematic reviews provide strong evidence for the clinical effectiveness of AIT in the treatment of AR. Cost-effectiveness and disease modification of AIT compared with standard drug treatment are additional advantages.

引用

页码：77 / +

页数：19

共 99 条

[1] Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens [J].

Akdis, Muebeccel ;

Akdis, Cezmi A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (03) :621-631

[2] Standards for practical allergen-specific immunotherapy [J].

Alvarez-Cuesta, E. ;

Bousquet, J. ;

Canonica, G. W. ;

Durham, S. R. ;

Mailing, H. -J. ;

Valovirta, E. .

ALLERGY, 2006, 61 :1-20

[3] Evaluation of near-fatal reactions to allergen immunotherapy injections [J].

Amin, HS ;

Liss, GM ;

Bernstein, DI .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :169-175

[4]

[Anonymous], 2003, CDC Fast Facts A-Z: Vital Health Statistics

[5]

[Anonymous], 2014, ORALAIR SWEET VERNAL

[6]

[Anonymous], 2014, RAGWITEKTM SHORT RAG

[7] Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: Results from the National Survey of Lead and Allergens in Housing [J].

Arbes, SJ ;

Cohn, RD ;

Yin, M ;

Muilenberg, ML ;

Friedman, W ;

Zeldin, DC .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) :111-117

[8] Abatement of cockroach allergen (Bla g 1) in low-income, urban housing: A randomized controlled trial [J].

Arbes, SJ ;

Sever, M ;

Archer, J ;

Long, EH ;

Gore, JC ;

Schal, C ;

Walter, M ;

Nuebler, B ;

Vaughn, B ;

Mitchell, H ;

Liu, E ;

Collette, N ;

Adler, P ;

Sandel, M ;

Zeldin, DC .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (02) :339-345

[9]

Ariano R, 2006, ALLERGY ASTHMA PROC, V27, P159

[10] Economic evaluation of sublinimal immunotherapy vs symptomatic treatment in allergic asthma [J].

Ariano, Renato ;

Berto, Patrizia ;

Incorvaia, Cristoforo ;

Di Cara, Giuseppe ;

Boccardo, Rachele ;

La Grutta, Stefania ;

Puccinelli, Paola ;

Frati, Franco .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (03) :254-259

← 1 2 3 4 5 6 7 8 9 10 →